Y, Z., W, C., H, J., Y, Z., Z, M., Z, W., . . . Z, C. (2024). MKI67 with arterial hypertension predict a poor survival for prostate cancer patients, a real-life investigation. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 26(12), 3037. https://doi.org/10.1007/s12094-024-03505-5
Chicago Style (17th ed.) CitationY, Zhou, et al. "MKI67 with Arterial Hypertension Predict a Poor Survival for Prostate Cancer Patients, a Real-life Investigation." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 26, no. 12 (2024): 3037. https://doi.org/10.1007/s12094-024-03505-5.
MLA (9th ed.) CitationY, Zhou, et al. "MKI67 with Arterial Hypertension Predict a Poor Survival for Prostate Cancer Patients, a Real-life Investigation." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, vol. 26, no. 12, 2024, p. 3037, https://doi.org/10.1007/s12094-024-03505-5.